The Effect of a Thromboxane Synthetase Inhibitor, OKY-046, On Urinary Excretion of Immunoreactive Thromboxane B2 and 6-Keto-Prostaglandin F1[alpha] in Patients With Ischemic Cerebrovascular Disease.
Uyama, Osamu M.D., Ph.D.; Nagatsuka, Kazuyuki M.D.; Nakabayashi, Saiji M.D.; Isaka, Yodhinari M.D.; Yoneda, Shotaro M.D., Ph.D.; Kimura, Kazufumi M.D., Ph.D.; Abe, Hiroshi M.D., Ph.D.
[Article]
Stroke.
16(2):241-244, March/April 1985.
(Format: HTML, PDF)
